Antisense oligonucleotides to gastrin inhibit growth of human pancreatic cancer

Cancer Letters

Volumn 135, Issue 1, 1998, Pages 107-112

  Smith, Jill Palmer ^a,b   Verderame, Michael F ^a   Zagon, Ian S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Gastrointestinal peptides; Phosphorothioate; Tumor biology

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GASTRIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER GROWTH; CELL PROLIFERATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; GASTRINS; GROWTH INHIBITORS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 0032445725     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00279-1     Document Type: Article

References (20)

1. [1] C.A. Stein, Antitumor effects of antisense phosphorothioate c-myc oligonucleotides: a question of mechanism, J. Natl. Cancer Inst. 88 (1996) 391-393.
2. [2] A.J. Baertschi, Antisense oligonucleotide strategies in physiology, Mol. Cell. Endocrinol. 101 (1994) R15-R24.
3. [3] C.M. Barton, N.R. Lemoine, Antisense oligonucleotides directed against p53 have antiproliferalive effects unrelated to effects on p53 expression, Br. J. Cancer 71 (1995) 429-437.
4. [4] J.P. Smith, A.P. Fantaskey, G. Liu, I.S. Zagon, Identification of gastrin as a growth peptide in human pancreatic cancer, Am. J. Physiol. 268 (1995) R135-R141.
5. [5] J.P. Smith, C.A. Rickabaugh, P.J. McLaughlin, I.S. Zagon, Cholecystokinin receptor and PANC-1 human pancreatic cancer cells, Am. J. Physiol. 265 (1993) G149-G155.
6. [6] J.P. Smith, G. Liu, V. Soundararajan, P.J. McLaughlin, I.S. Zagon, Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines, Am. J. Physiol. 266 (1994) R277-R283.
7. [7] J.P. Smith, A. Shih, Y. Wu, P.J. McLaughlin, I.S. Zagon, Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion, Am. J. Physiol. 270 (1996) R1078-R1084.
8. [8] M.H. Tan, N.J. Nowak, R. Loor, H. Ochi, A.A. Sandberg, C. Lopez, J.W. Picren, R. Berjian, H.O. Douglass Jr., T.M. Chu, Characterization of a new primary human pancreatic tumor line, Cancer Invest. 4 (1986) 15-23.
9. [9] M.L. Frazier, N. Brown, S. Pathak, B. Mackay, K. Cleary, M. Olive, D.R. Byrd, D.B. Evans, B. Levin, Human cell line from an adenocarcinoma of the ampulla of Vater, In Vitro Cell. Dev. Biol. 28A (1992) 149-153.
10. [10] M.W. Hamory, M.F. Verderame, I.S. Zagon, J.P. Smith, Measurement of gastrin mRNA by quantitative PCR in normal and cancerous human pancreas, Gastroenterology 110 (1996) A525.
11. [11] J.P. Smith, T.E. Solomon, S. Bagheri, S. Kramer, Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990, Dig. Dis. Sci. 35 (1990) 1377-1384.
12. [12] M.A. Bradford, A rapid and sensitive technique for the quantification of microgram amounts of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
13. [13] J.G. Forte, J.M. Wolsin, HCl secretion by the gastric oxyntic cell, in: L.R. Johnson (Ed.), Physiology of the Gastrointestinal Tract, Raven Press, New York, 1987, pp. 853-863.
14. [14] L.R. Johnson, Regulation of gastrointestinal growth, in: L.R. Johnson (Ed.), Physiology of the Gastrointestinal Tract, Raven Press, New York, 1987, pp. 301-334.
15. [15] J.R. Upp Jr., P. Singh, C.M. Townsend Jr., J.C. Thompson, Clinical significance of gastrin receptors in human colon cancers, Cancer Res. 49 (1989) 488-492.
16. [16] J.P. Smith, E. Stock, M.G. Wotring, P.J. McLaughlin, I.S. Zagon, Characterization of the CCK-B/gastrin-like receptor in human colon cancer, Am. J. Physiol. 271 (1996) R796-R805.
17. [17] S.A. Watson, L.G. Durrant, D.L. Morris, Growth promoting effects on human gastric and colonie tumour cells, Br. J. Cancer 59 (1989) 554-558.
18. [18] J.P. Smith, A.H. Shih, M.G. Wotring, P.J. McLaughlin, I.S. Zagon, Characterization of CCK-B/gastrin-like receptor in human gastric carcinoma, Int. J. Oncol. 12 (1998) 411-419.
19. [19] A. Storey, D. Oates, L. Banks, L. Crawford, T. Crook, Antisense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16, Nucleic Acids Res. 19 (1991) 4109-4114.
20. [20] R.W. Wagner, Gene inhibition using antisense oligonucleotides, Nature 372 (1994) 333-335.